Jennifer L Steiner1, Silvia M Bigatti2, James E Slaven3, Dennis C Ang4. 1. Atlanta Veteran's Affairs Medical Center, Decatur GA. 2. Indiana University, Richard M. Fairbanks School of Public Health, Indianapolis. 3. Indiana University School of Medicine, Department of Biostatistics, Indianapolis. 4. Wake Forest University School of Medicine.
Abstract
PURPOSE: Fibromyalgia (FM) is typically associated with the experience of diffuse pain and physical impairment. Depression also commonly co-exists in patients with FM, and has been correlated with pain intensity and physical functioning. Previous research suggests an association between pain intensity and physical functioning; however, the direct causal relationship between improvements in pain intensity and in functioning is not observed in many FM patients. This may suggest that another factor such as depression is mediating this relationship. The present work examined mediating role of depression. METHODS: 216 patients with FM completed measures of pain intensity, depression, and physical function as part of a larger longitudinal study. Assessments were completed at baseline, 12, 24, and 36 weeks. RESULTS: Longitudinal mediational analyses indicated that depression is a partial mediator of the relationship between pain intensity and physical functioning at all four assessment points. Beta coefficients for the path from pain to physical functioning ranged from 0.18 - 0.36, with attenuated path coefficients ranging from 0.03 - 0.08, still showing significant but decreased associations when depression was added as a mediator. CONCLUSIONS: Clinical implication includes the importance of treating co-morbid depression in patients with fibromyalgia early in the course of treatment to prevent engagement in the cycle of disability.
PURPOSE:Fibromyalgia (FM) is typically associated with the experience of diffuse pain and physical impairment. Depression also commonly co-exists in patients with FM, and has been correlated with pain intensity and physical functioning. Previous research suggests an association between pain intensity and physical functioning; however, the direct causal relationship between improvements in pain intensity and in functioning is not observed in many FM patients. This may suggest that another factor such as depression is mediating this relationship. The present work examined mediating role of depression. METHODS: 216 patients with FM completed measures of pain intensity, depression, and physical function as part of a larger longitudinal study. Assessments were completed at baseline, 12, 24, and 36 weeks. RESULTS: Longitudinal mediational analyses indicated that depression is a partial mediator of the relationship between pain intensity and physical functioning at all four assessment points. Beta coefficients for the path from pain to physical functioning ranged from 0.18 - 0.36, with attenuated path coefficients ranging from 0.03 - 0.08, still showing significant but decreased associations when depression was added as a mediator. CONCLUSIONS: Clinical implication includes the importance of treating co-morbid depression in patients with fibromyalgia early in the course of treatment to prevent engagement in the cycle of disability.
Authors: Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield Journal: J Rheumatol Date: 2011-02-01 Impact factor: 4.666
Authors: Dennis C Ang; Rafael Chakr; Steve Mazzuca; Christopher R France; Jennifer Steiner; Timothy Stump Journal: Arthritis Care Res (Hoboken) Date: 2010-05 Impact factor: 4.794
Authors: Nada Lukkahatai; Brian Walitt; Alexandra Espina; Alves Gelio; Leorey N Saligan Journal: Arthritis Care Res (Hoboken) Date: 2016-01 Impact factor: 4.794
Authors: Willem J Kop; Angela Lyden; Ali A Berlin; Kirsten Ambrose; Cara Olsen; Richard H Gracely; David A Williams; Daniel J Clauw Journal: Arthritis Rheum Date: 2005-01
Authors: Anthony S Kaleth; Silvia M Bigatti; James E Slaven; Nicholas Kelly; Dennis C Ang Journal: J Clin Rheumatol Date: 2022-01-01 Impact factor: 3.517
Authors: Arya B Mohabbat; Saswati Mahapatra; Sarah M Jenkins; Brent A Bauer; Ann Vincent; Dietlind L Wahner-Roedler Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2019-10-16
Authors: Mari Aguilera; Clara Paz; Marta Salla; Victoria Compañ; Joan Carles Medina; Leticia Medeiros-Ferreira; Guillem Feixas Journal: Int J Clin Health Psychol Date: 2022-02-23
Authors: Giorgia Varallo; Carlos Suso-Ribera; Ada Ghiggia; Marco Veneruso; Roberto Cattivelli; Anna Guerrini Usubini; Christian Franceschini; Alessandro Musetti; Giuseppe Plazzi; Jacopo Maria Fontana; Paolo Capodaglio; Gianluca Castelnuovo Journal: J Pain Res Date: 2022-09-26 Impact factor: 2.832
Authors: Cecilia Peñacoba; Irene López-Gómez; Maria Angeles Pastor-Mira; Sofía López-Roig; Carmen Ecija Journal: PLoS One Date: 2021-07-08 Impact factor: 3.240